Download

Full Text

• Radin MJ, Sharkey LC, Holycross BJ. Adipokines: A review of biological and analytical principles and an update in dogs, cats, and horses. Vet Clin Pathol 2009;38:136-156.
• Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-2921.
• Fang X, Palanivel R, Cresser J, et al. An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab 2010;299:721-729.
• Ganguly R, Schram K, Fang X, et al. Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes. Endocrinology 2011;152:247-254.
• Konishi M, Haraguchi G, Ohigashi H, et al. Adiponectin protects against doxorubicin induced cardiomyopathy by antiapoptotic effects through AMPK upregulation. Cardiovasc Res 2011;89:309-319.
• Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
• Chen CY, Asakura M, Asanuma H, et al. Plasma adiponectin levels predict cardiovascular events in the observational Arita Cohort Study in Japan: The importance of the plasma adiponectin levels. Hypertens Res 2012;35:843-848.
• Li Q, Lu Y, Sun L, et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metabolism 2012;61:1803-1808.
• Beatty AL, Zhang MH, Ku IA, et al. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: Data from the Heart and Soul Study. Atherosclerosis 2012;220:587-592.
• Verkest K, Rose F, Fleeman L, et al. Adiposity and adiponectin in dogs: Investigation of causes of discrepant results between two studies. Domest Anim Endocrinol 2011;41:34-41.
• Verkest KR, Bjornvad CR. Guest Editorial: Understanding adiponectin in dogs and cats: A work in progress. Vet J 2012;193:4-5.
• Dukes-McEwan J, Borgarelli M, Tidholm A, et al. Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. J Vet Cardiol 2003;5:7-19.
• Fox PR, Sisson D, Moïse NS, et al. Appendix A: Recommendations for diagnosis of heart disease and treatment of heart failure in small animals. In: Fox PR, Sisson DD, Moise NS, eds. Textbook of Canine and Feline Cardiology Principles and Clinical Practice, 2nd ed. St Louis, MO: WB Saunders Company; 1999:883-901.
• Tvarijonaviciute A, Martínez-Subiela S, Ceron JJ. Validation of 2 commercially available enzyme-linked immunosorbent assays for adiponectindetermination in canine serum samples. Can J Vet Res 2010;74:279-285.
• Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Hillsdale, NJ: Erlbaum; 1988;567 pp.
• Trujillo ME, Sherer PE. Adiponectin-Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005;257:167-175.
• Ricci R, Bevilacqua F. The potential role of leptin and adiponectin in obesity: A comparative review. Vet J 2012;191:292-298.
• Gayet C, Leray V, Saito M, et al. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs. Br J Nutr 2007;98:497-503.
• Ishioka K, Omachi A, Sagawa M, et al. Canine adiponectin: cDNA structures, mRNA expression in adipose tissues and reduced plasma levels in obesity. Res Vet Sci 2006;80:127-132.
• Tvarijonaviciute A, Ceron JJ, Holden SL, et al. Obesity-related metabolic dysfunction in dogs: A comparison with human metabolic syndrome. BMC Vet Res 2012;8:147.
• Tvarijonaviciute A, Tecles F, Martinez-Subiela S, Ceron JJ. Effect of weight loss on inflammatory biomarkers in dogs. Vet J 2012;193:570-572.
• Grant RW, Vester Boler BM, Ridge TK, et al. Adipose tissue transcriptome changes during obesity development in female dogs. Physiol Genomics 2001;43:295-307.
• German AJ, Hervera M, Hunter L, et al. Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol 2009;37:214-226.
• Mazaki-Tovi M, Abood SK, Schenck PA. Effect of omega-3 polyunsaturated fatty acids and body condition on serum concentrations of adipokines in healthy dogs. Am J Vet Res 2012;73:1273-1281.
• Mitsuhashi Y, Nagaoka D, Ishioka K. Postprandial lipid-related metabolites are altered in dogs fed dietary diacylglycerol and low glycemic index starch during weight loss. J Nutr 2010;140:1815-1823.
• Verkest KR, Fleeman L, Morton J, Rand JS. Compensation for obesity-induced insulin resistance in dogs: Assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis. Domest Anim Endocrinol 2011;41:24-34.
• Wakshlag JJ, Struble AM, Levine CB, et al. The effects of weight loss on adipokines and markers of inflammation in dogs. Br J Nutr 2011;106:11-14.
• Tvarijonaviciute A, Martínez-Subiela S, Carrillo-Sanchez JD. Effects of orchidectomy in selective biochemical analytes in Beagle dogs. Reprod Domest Anim 2011;46:957-963.
• Böttner A, Kratzsch J, Müller G, et al. Gender differences of adiponectin levels develop during progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004;89:4053-4061.
• Xu A, Chan KW, Hoo RL, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005;280:18073-18080.
• Kizer JR, Arnold AM, Strotmeyer ES, et al. Change in circulating adiponectin in advanced old age: Determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci 2010;65:1208-1214.
• Atzmon G, Pollin TI, Crandall J, et al. Adiponectin levels and genotype: A potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 2008;63:447-453.
• Papadopoulos DP, Makris TK, Perrea D, et al. Adiponectin, insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension. Blood Press 2008;17:50-54.
• Breitfeld J, Stumvoll M, Kovacs P. Genetics of adiponectin. Biochimie 2012;94:2157-2163.
• Tvarijonaviciute A, Ceron JJ, Tecles F. Serum adiponectin concentration in dogs-Absence of diurnal variation and lack of effect of feeding and methylprednisolone administration. Acta Vet Hung 2012;30:489-500.
• George J, Patal S, Wexler D, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006;92:1420-1424.
• Yin WH, Wei J, Huang WP, et al. Prognostic value of circulating adipokine levels and expressions of adipokines in the myocardium of patients with chronic heart failure. Circ J 2012;76:2139-2147.
• Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;20:1756-1762.
• Khan RS, Kato TS, Chokshi A, et al. Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: Correction after ventricular assist device implantation. Circ Heart Fail 2012;5:340-348.
• Ohara T, Hashimura K, Asakura M, et al. Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure. J Cardiol 2011;58:181-190.
• Schulze PC, Biolo A, Gopal D. Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure. J Card Fail 2011;17:1004-1011.
• Matsumoto M, Lee-Kawabata M, Tsujino T, et al. Decrease in serum adiponectin levels in response to treatment predicts good prognosis in acute decompensated heart failure. J Clin Hypertens 2010;12:900-904.
• Van Berendoncks AM, Garnier A, Beckers P, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail 2010;3:185-194.
• Chang LC, Huang KC, Wu YW, et al. The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc 2009;108:353-366.